Designing a catalyst is incredibly difficult—yet researchers at Tohoku University have successfully created a catalyst that ...

Regenxbio's RGX-121 gene therapy for Hunter syndrome is the main catalyst, with FDA approval targeted for February 2026.

Experiments on domestic chicks shed light on the links between brain lateralization and the left-to-right mental number line.

As a compromise, many chipmakers divide all chips into a few bins, such as slow/fast/typical, setting a single voltage level per bin. However, due to the substantial variation in each bin, many units ...

What makes designing catalysts so difficult is obtaining the right balance of traits that speeds up the OER as much as ...